氨基-N-(4-甲氧基苯基)乙酰胺 | 148627-63-8

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 中文名称: 氨基-N-(4-甲氧基苯基)乙酰胺
• 英文名称: 2-amino-N-(4-methoxyphenyl)acetamide
• CAS: 148627-63-8
• 化学式: C₉H₁₂N₂O₂
• mdl: MFCD09724250
• 分子量: 180.206
• InChiKey: MAVJTZKUNOKGPF-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.1
• 重原子数：
  13
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.222
• 拓扑面积：
  64.4
• 氢给体数：
  2
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  氨基-N-(4-甲氧基苯基)乙酰胺 在 silver nitrate 、 三乙胺 、 copper(I) bromide 作用下， 以 甲苯 、 乙腈 为溶剂， 反应 4.25h， 生成 (2Z,5E)-tert-butyl 4-(2-bromophenyl)-2-(tert-butoxycarbonylimino)-5-(4-tert-butylbenzylidene)-3-(2-(4-methoxyphenylamino)-2-oxoethyl)imidazolidine-1-carboxylate
  参考文献：
  名称：

  Polysubstituted 2-aminoimidazoles as anti-biofilm and antiproliferative agents: Discovery of potent lead

  摘要：

  Most of the human bacterial infections are associated with the biofilm formation and the natural tolerance of biofllms to antibiotics,challenges treatment. Because of their low immunity, cancer patients are especially susceptible to bacterial infections. Compounds with anti-biofilm activity could therefore become a useful adjunct to chemotherapy, in particular if they also show antiproliferative activities. Taking this into consideration and as a result of our continuous interest in 2-aminoimidazole derivatives, we have designed and synthesized a series of novel polysubstituted 2-aminoimidazoles (20a-x). The compounds were evaluated against a panel of three bacterial strains for their biofilm and planktonic growth inhibitory activity and most of them show promising results. Furthermore, the synthesized compounds were evaluated against various cancer cell lines and almost all the compounds were found to possess potent antiproliferative activity. The substitution pattern at the C-4 position and the aryl carboxamide ring at the N-1 position have major effects on the biofilm inhibitory and antiproliferative activity. Especially, the introduction of a p-methyl group at the carboxamide ring remarkably enhances both the anti-biofilm and antiproliferative activity. The two most potent compounds (20i & 20r) were further studied for their antiproliferative activity and a flow cytometer-based cell cycle experiment was performed, which revealed their capability to induce G2/M phase cell cycle arrest. Based on these results, these two new compounds having potential to target both cancer proliferation and microbial biofllms might be used in single drug monotherapy. (C) 2017 Elsevier Masson SAS. All rights reserved.

  DOI：

  10.1016/j.ejmech.2017.06.043
• 作为产物：
  描述：

  2-氨基-N-(4-甲氧基苯基)丙酰胺 在 N-甲基咪唑 、 氰基磷酸二乙酯 、 N,N-二异丙基乙胺 、 丙酮 、 三氟乙酸 作用下， 以 四氢呋喃 、 N,N-二甲基甲酰胺 、 异丙醇 为溶剂， 反应 13.5h， 生成 氨基-N-(4-甲氧基苯基)乙酰胺
  参考文献：
  名称：

  N-Substituted 2-(2,6-Dinitrophenylamino)propanamides:  Novel Prodrugs That Release a Primary Amine via Nitroreduction and Intramolecular Cyclization

  摘要：

  A series of N-dinitrophenylamino acid amides [(4-CONHZ-2,6-diNO(2)Ph)N(R)C(X,Y)CONHPhOMe] were prepared as potential bioreductive prodrugs and reduced radiolytically to study their rates of subsequent intramolecular cyclization. Compounds bearing a free NH group (R = H) underwent rapid cyclization in neutral aqueous buffers (t(1/2) < 1 min) following 4-electron reduction, with the generation of a N-hydroxydihydroquinoxalinone and concomitant release of 4-methoxyaniline. Amine release from analogous N-methyl analogues (R = Me) was relatively slow. These results are consistent-with intramolecular cyclization of a monohydroxylamine intermediate. The high rates of cyclization/extrusion by these very electron-deficient hydroxylamines suggest that the process is greatly accelerated by the presence of an H-bonding "conformational lock" between the anilino NH group and the adjacent o-nitro group (Kirk and Cohen, 1972). Changes in the phenylcarboxamide side chain or in C-methylation in the linking chain had little effect-on the rate of cyclization. The model compounds had 1-electron reduction potentials in the range appropriate for cellular reduction (-373 mV for a measured example) and appeared suitable for development as prodrugs that release amine-based effecters following enzymic or radiolytic reduction. Prodrug examples containing 4-aminoaniline mustard and 5-amino-1-(chloromethyl)benz[e]indoline alkylating units were evaluated but were not activated efficiently by cellular nitroreductases. However, cell killing by the radiation-induced reduction of the latter prodrug was demonstrated.

  DOI：

  10.1021/jm960783s

文献信息

• New isoleucine derived dipeptides as antiprotozoal agent: Synthesis, in silico and in vivo studies.
  作者：Ogechi C. Ekoh、Uchechukwu C. Okoro、Rafat Ali、David I. Ugwu、Sunday N. Okafor、James A. Ezugwu

  DOI：10.1016/j.molstruc.2021.130017

  日期：2021.5

  aceturate. In the antimalarial study, 11b was the most active compound, even better than the standard. Molecular docking result suggests good interaction between the reported compounds and the target protein. The results of haematological analysis, liver and kidney function tests showed that the compounds had no adverse effect on the blood and organs. Compound 11b stands out among the derivatives haven shown

  疟疾耐药性寄生虫的出现越来越多，锥虫病的有效化学疗法不足，代表了热带地区传染病治疗的巨大挑战。关于开发有效的抗原生动物剂，通过使用肽偶联剂将化合物（10）与（8a-j）缩合，合成了十种新的甘草二肽磺酰胺衍生物。化合物11b，11i和11j最能清除11b小鼠的锥虫布氏锥虫，并具有与醋酸二米那嗪相当的活性。在抗疟疾研究中，11b是活性最高的化合物，甚至优于标准化合物。分子对接结果表明所报道的化合物与靶蛋白之间具有良好的相互作用。血液学分析，肝和肾功能测试的结果表明该化合物对血液和器官没有不良影响。化合物11b在衍生物中脱颖而出，这些衍生物在抗疟和抗锥虫试验中均显示出更好的活性。
• Design, synthesis and biological evaluation of novel naturally-inspired multifunctional molecules for the management of Alzheimer’s disease
  作者：Yash Pal Singh、Gullanki Naga Venkata Charan Tej、Amruta Pandey、Khushbu Priya、Pankaj Pandey、Gauri Shankar、Prasanta Kumar Nayak、Geeta Rai、Amar G. Chittiboyina、Robert J. Doerksen、Swati Vishwakarma、Gyan Modi

  DOI：10.1016/j.ejmech.2020.112257

  日期：2020.7

  the management of Alzheimer's disease and to develop in-vivo active multifunctional cholinergic inhibitors, we embarked on the development of ferulic acid analogs. A systematic SAR study to improve upon the cholinesterase inhibition of ferulic acid with analogs that also had lower logP was carried out. Enzyme inhibition and kinetic studies identified compound 7a as a lead molecule with preferential

  为了克服克服与天然产物有关的阿尔茨海默氏病管理的局限性并开发体内活性多功能胆碱能抑制剂的总体目标，我们着手开发阿魏酸类似物。进行了系统的SAR研究，以改善LogP值较低的类似物对阿魏酸对胆碱酯酶的抑制作用。酶抑制和动力学研究确定化合物7a为具有优先乙酰胆碱酯酶抑制作用的先导分子（AChE IC50 = 5.74±0.13μM; BChE IC50 = 14.05±0.10μM）与母体阿魏酸（20μM时AChE和BChE的抑制％ ，分别为15.19±0.59和19.73±0.91）。分子对接和动力学研究表明7a非常适合AChE和BChE的活性位点，与AChE中的关键残基Asp74，Trp286和Tyr337以及BChE中的Tyr128，Trp231，Leu286，Ala328，Phe329和Tyr341形成稳定而强的相互作用。在DPPH分析中发现化合物7a是有效的抗氧化剂（IC50 = 57
• Pyreneamide-based dipodal probes for ultra-sensitive and selective detection of 3,5-dinitrosalicylic acid in an aqueous solution
  作者：Ashwani Kumar、Pil Seok Chae

  DOI：10.1016/j.dyepig.2017.08.039

  日期：2017.12

  Pyrene-appended dipodal probes (probes 1 and 2) with differences in conformational rigidity were synthesized for sensitive detection of 3,5-dinitrosalicylic acid (DNSA) in an aqueous solution. Both dipodal probes had two pyrene units and exhibited quenching caused by aggregation (ACQ) at high water content (>60%) in DMSO. As the pyrene dimer (e.g., excimer) was a dominant conformation in 99% aqueous

  合成了构象刚度不同的带有-的二足探针（探针1和2），用于灵敏检测水溶液中的3,5-二硝基水杨酸（DNSA）。两个二脚架探针均具有两个pyr单元，并且在高DMSO中的高水分含量（> 60％）下表现出由聚集（ACQ）引起的猝灭。由于the二聚体（例如，受激准分子）是在99％水溶液中的主要构象，因此激发后，两个探针在486 nm（探针1）或480 nm（探针2）上均显示出足够的准分子发射强度。探针（探针1和2）的准分子发射在DNSA存在下被灵敏地淬灭。探针1在各种羧酸（CA）中对DNSA有选择性的响应，而探针2对DNSA和5-NSA都有响应。密度泛函理论（DFT）计算表明，在存在DNSA的情况下，探针会发生结构变化，从而导致探针的每个pyr单元与客体分子的苯环之间形成新的π - π相互作用。这种新的π - π相互作用使能量能够从to转移到非辐射客体分子（DNSA），从而导致探针中的荧光猝灭。探针
• COMPOUNDS WHICH HAVE A PROTECTIVE ACTIVITY WITH RESPECT TO THE ACTION OF TOXINS AND OF VIRUSES WITH AN INTRACELLULAR MODE OF ACTION
  申请人：Commissariat A L'Energie Atomique Et Aux Energies Alternatives

  公开号：US20160083355A1

  公开（公告）日：2016-03-24

  The subject matter of the present invention is novel families of compounds which are aromatic amine, imine, aminoadamantane and benzodiazepine derivatives, medicaments comprising same and the use thereof as inhibitors of the toxic effects of toxins with intracellular activity, such as, for example, ricin, and of viruses that use the internalization pathway for infecting cells.

  本发明的主题是新型化合物家族，其中包括芳香胺、亚胺、氨基金刚烷和苯二氮卓衍生物，包括相同的药物和将其用作抑制具有细胞内活性的毒素（例如蓖麻毒素）以及利用内化途径感染细胞的病毒的药物。
• BIARYL-SUBSTITUTED TETRAHYDRO-PYRAZOLO-PYRIDINE MODULATORS OF CATHEPSIN S
  申请人：Allen Darin

  公开号：US20080207683A1

  公开（公告）日：2008-08-28

  Biaryl-substituted tetrahydro-pyrazolo-pyridine compounds are described, which are useful as cathepsin S modulators. Such compounds may be used in pharmaceutical compositions and methods for the treatment of disease states, disorders, and conditions mediated by cathepsin S activity, such as psoriasis, pain, multiple sclerosis, atherosclerosis, and rheumatoid arthritis.

  所述的双芳基取代的四氢吡唑吡啶化合物被描述为对半胱氨酸蛋白酶S的调节剂。这些化合物可用于制备药物组合物和治疗由半胱氨酸蛋白酶S活性介导的疾病状态、疾病和病况的方法，如银屑病、疼痛、多发性硬化、动脉粥样硬化和类风湿性关节炎。